This study reveals how signals from the suprachiasmatic nucleus coordinate the metabolic flexibility of BAT, through a adrenergic receptor ADRB3-S100B signaling axis, thereby identifying a new therapeutic target for metabolic disorders. Here, ADRB3 is linked to Other metabolic disease.